In a major breakthrough Tuesday, researchers announced that the vaccine candidate RTS,S reduces the risk of malaria by half in children ages five to 17 months, first results from a continuing phase three trial showed. The results have tremendous implications, as malaria is responsible for nearly 800,000 deaths annually. The disease kills one child every 45 seconds in Africa, where it accounts for approximately 20 percent of childhood deaths, according to...
More »SEARCH RESULT
Total Matching Records found : 190
Fertility drug ban after 4 years of use by GS Mudur
The Union health ministry today banned the manufacture and sale of a drug called letrozole to treat infertility in women, four years after its own drug regulators had waived safety studies and relaxed rules to approve the medicine. In a statement notifying the ban, the ministry said the drug “is likely to involve risk to human beings and safer alternatives are available”. The drug has been used to treat breast cancer in...
More »A Pail Of Piety Against An Augean Stable by Pranab Bardhan
There are structural aspects to a problem as complex as corruption. These cannot be tackled through punishment alone. Just as our society tends to latch on to holy men for miracle cures, in recent weeks, the urban middle classes have placed great hopes on an anti-corruption movement led by a pious man in a Gandhi cap. (The other claim on leadership by a holy man in red robes did not...
More »Useless pharmaceutical studies cause real harm by Carl Elliott
Last month, the Archives of Internal Medicine published a scathing reassessment of a 12-year-old research study of Neurontin, a seizure drug made byPfizer. The study, which had included more than 2,700 subjects and was carried out by Parke-Davis (now part of Pfizer), was notable for how poorly it was conducted. The investigators were inexperienced and untrained, and the design of the study was so flawed it generated few if any...
More »UN hails studies showing antiretroviral drugs can prevent HIV infection
-The United Nations The United Nations today welcomed the results of studies that show that taking a tablet of an antiretroviral drug daily can reduce the risk of acquiring HIV by up to 73 per cent in people not infected by the virus that causes AIDS. The findings of the studies carried out in Kenya, Uganda and Botswana, showed that daily use of both tenofovir and tenofovir/emtricitabine antiretrovirals, taken as preventive...
More »
